Anonymous A-Listers Lobby Congress Against Netflix-WBD Acquisition

An anonymous consortium of prominent feature film producers has sent an urgent open letter to Congress urging the highest level of antitrust scrutiny of Netflix’s proposed acquisition of Warner Bros. Discovery, warning the deal could 'destroy' the theatrical marketplace by collapsing the theatrical window to as little as two weeks. The group, which cites Netflix co-CEO Ted Sarandos' comments that theatrical distribution is not Netflix’s business, argues a combined Netflix-HBO Max could shrink theatrical footprints and depress post-theatrical licensing fees, a concern underscored by rival bidders (Comcast and Paramount) who retain theatrical distribution and, in Paramount’s case, have pledged at least 14 theatrical releases per year for Warner Bros.

Analysis

Market structure: A Netflix (NFLX) acquisition of Warner Bros. Discovery (WBD) would concentrate content distribution and could shift pricing power from theatrical exhibitors to a combined streaming gatekeeper; expect downward pressure on post-theatrical licensing fees (potentially 20–40% over 12–24 months if theatrical windows compress to ~2 weeks) and a reallocation of box-office share toward fewer tentpoles. Comcast (CMCSA) and other buyers with theatrical footprints are direct beneficiaries in a blocked-deal scenario; exhibitors and distributors see demand risk and potential long-term volume declines.

Risk assessment: Tail risks include a DOJ/FTC injunction or forced divestiture (high-impact, moderate probability over 6–12 months), a hostile price war that forces Netflix to overpay and take a >$5–15bn goodwill write-down, or coordinated industry blacklisting of Netflix releases hurting subscriber growth. Immediate (days) impact = elevated implied volatility in NFLX/WBD; short-term (weeks–months) = regulatory hearings and rival bids; long-term (2–5 years) = structural shift in windows, talent contract renegotiations, and exhibitor consolidation.

Trade implications: Tactical relative-value: favor CMCSA exposure and hedge/short NFLX beta — CMCSA should outperform if deal blocked or regulated; expect NFLX implied vol to spike on filings so use 3–6 month put spreads to limit cost. Opportunistically buy WBD credit if senior bond prices trade <85 (yield >8%) because downside is limited in a divestiture. Reduce exposure to theatrical-REITS and exhibitors (real assets) by 3–5%.

Contrarian angles: The market assumes theatre death but studios still need theatrical marketing for $200M+ tentpoles — a blended window model could preserve box office for top titles. Regulators blocking the deal could leave WBD impaired and create an undervalued asset for a disciplined buyer; historically (Amazon–MGM, Disney–Fox) scrutiny delays but does not always destroy strategic value. Watch for overreactions in NFLX near-term that create entry points for longer-dated hedged longs.

Key Decisions for Investors

• Establish a 2–3% long position in CMCSA common stock within 7–30 days, funded by a 1–2% short in NFLX; thesis: CMCSA captures upside if deal blocked and benefits from preserved theatrical windows.
• Initiate short-dated (3–6 month) NFLX 10% OTM put spreads sized at 0.5–1% notional to hedge equity exposure and monetize elevated implied volatility around regulatory milestones (max loss = spread width).
• If WBD senior bonds trade below 85 (implied yield >8%), allocate 1–2% notional to purchase those bonds for yield pickup and restructuring optionality; set stop-loss at price 75.
• Reduce exposure to theater/exhibitor and cinema-adjacent REIT names by 3–5% and reallocate to cable/broadband consumer staples (CMCSA) within 30 days to lower structural-box-office risk.
• Monitor regulatory catalysts over next 30–90 days (DOJ/FTC filings, Congressional hearings, competing bid announcements); only add concentrated long WBD equity if share price falls >25% on blocked-deal headline or if a rival bid fails to materialize.